Literature DB >> 28497379

[Choosing wisely recommendations in cardiology].

K Werdan1,2, S Baldus3,4, N Frey3,5, U Nixdorff3,6, K-H Kuck3,7, H Katus3,8.   

Abstract

This article describes controversially discussed Choosing wisely recommendations presented by the German Cardiac Society: anticoagulation therapy in patients with atrial fibrillation and "only" moderate stroke risk, on the one hand, and goal-directed low-density lipoprotein (LDL) cholesterol-lowering, on the other. Presuming an adequate regime, patients with atrial fibrillation and only moderate risk of stroke (CHA2DS2-VASc Score of 1 in men and of 2 in women) also benefit from anticoagulation therapy, even in elderly patients. In patients with coronary heart disease, the German Cardiac Society recommends reducing LDL-cholesterol serum levels with a statin to values lower than 70 mg/dl (1.8 mmol/l) or at least reducing the basal level by 50%. With this recommendation, the German Cardiac Society unequivocally prioritizes the "goal-oriented statin therapy" above the "statin strategy of fixed dose". The reasons for this preference are discussed.

Entities:  

Keywords:  Anticoagulants; Atrial fibrillation; Cholesterol, LDL; Coronary disease; Hydroxymethylglutaryl-CoA reductase inhibitors

Mesh:

Substances:

Year:  2017        PMID: 28497379     DOI: 10.1007/s00108-017-0239-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  29 in total

1.  Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents.

Authors:  Paul M Ridker; Samia Mora; Lynda Rose
Journal:  Eur Heart J       Date:  2016-02-24       Impact factor: 29.983

2.  Choosing wisely--the politics and economics of labeling low-value services.

Authors:  Nancy E Morden; Carrie H Colla; Thomas D Sequist; Meredith B Rosenthal
Journal:  N Engl J Med       Date:  2014-01-22       Impact factor: 91.245

3.  [Prevention of cardiovascular events : Heart Outcomes Prevention Evaluation (HOPE)].

Authors:  W Koenig; S Nitschmann
Journal:  Internist (Berl)       Date:  2016-12       Impact factor: 0.743

4.  Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.

Authors:  Gregory Y H Lip; Lars Frison; Jonathan L Halperin; Deirdre A Lane
Journal:  J Am Coll Cardiol       Date:  2010-11-24       Impact factor: 24.094

5.  Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation.

Authors:  Gregory Y H Lip
Journal:  Am J Med       Date:  2010-09-29       Impact factor: 4.965

Review 6.  Stroke prevention in atrial fibrillation: a systematic review.

Authors:  Gregory Y H Lip; Deirdre A Lane
Journal:  JAMA       Date:  2015-05-19       Impact factor: 56.272

7.  Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Authors:  Salim Yusuf; Jackie Bosch; Gilles Dagenais; Jun Zhu; Denis Xavier; Lisheng Liu; Prem Pais; Patricio López-Jaramillo; Lawrence A Leiter; Antonio Dans; Alvaro Avezum; Leopoldo S Piegas; Alexander Parkhomenko; Katalin Keltai; Matyas Keltai; Karen Sliwa; Ron J G Peters; Claes Held; Irina Chazova; Khalid Yusoff; Basil S Lewis; Petr Jansky; Kamlesh Khunti; William D Toff; Christopher M Reid; John Varigos; Gregorio Sanchez-Vallejo; Robert McKelvie; Janice Pogue; Hyejung Jung; Peggy Gao; Rafael Diaz; Eva Lonn
Journal:  N Engl J Med       Date:  2016-04-02       Impact factor: 91.245

8.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

Authors:  C Baigent; L Blackwell; J Emberson; L E Holland; C Reith; N Bhala; R Peto; E H Barnes; A Keech; J Simes; R Collins
Journal:  Lancet       Date:  2010-11-08       Impact factor: 79.321

9.  A standardized bleeding risk score aligns anticoagulation choices with current evidence.

Authors:  Arielle S Berger; Andrew S Dunn; Amy S Kelley
Journal:  Crit Pathw Cardiol       Date:  2014-09

10.  Quality of care in patients with atrial fibrillation in primary care: a cross-sectional study comparing clinical and claims data.

Authors:  Rebekka Preuss; Jean-François Chenot; Aniela Angelow
Journal:  Ger Med Sci       Date:  2016-11-23
View more
  1 in total

1.  [Acute coronary syndrome : Prevention].

Authors:  U Nixdorff; G Horstick; A Schlitt
Journal:  Herz       Date:  2019-02       Impact factor: 1.443

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.